muscle mass loss with glp 1 and Weighing the risk of GLP-1 treatment in older adults: Should we be concerned about sarcopenic obesity? Do GLP-1 Drugs Cause Too – Study finds GLP-1 receptor agonists

Semaglutide users have reported an average weight loss of 15% of initial body weight, while Tirzepatide users have seen losses of 21% to 25%

After that, clinical studies and post-release surveillance observations showed that individuals prescribed the drug were also losing weight

According to a December 2025 YouGov survey, exercising more topped Americans' New Year's resolutions for 2026 , with 25% of respondents listing it as their primary goal

Clinical trials show LDL cholesterol reductions of 17% and triglyceride reductions of 515%, significantly less than statins

This is why at iThrive, every journey begins with a Root Cause Analysis